About AlphaCore Pharma
AlphaCore Pharma is a Healthcare company based in Ann Arbor (United States) founded in 2007, and was acquired by MedImmune in April 2013. It develops protein therapeutics for treating cardiovascular diseases like atherosclerosis. It operates on a B2B model. Its website alphacorepharma.com draws about 681 thousand monthly visits. Its focus areas include Biotechnology, Therapeutics and Protein Treatments. Its competitors include Portola Pharma, MyoKardia and Cellino; 3 of its 3 listed competitors have raised funding.
Company details
AlphaCore Pharma, based in Ann Arbor, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and protein treatments. Develops protein therapeutics for treating cardiovascular diseases like atherosclerosis. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Ann Arbor, United States
- Stage Acquired
- SectorsHealthcare
- Website alphacorepharma.com
- Acquired by MedImmune (Apr 2013)
Investors in AlphaCore Pharma
AlphaCore Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MedImmune.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biologic R&D for oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases | 1987 | medimmune.com | Gaithersburg, United States |
Investor details for AlphaCore Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AlphaCore Pharma
2 dated milestones of AlphaCore Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded AlphaCore Pharma is founded.
- Exit Acquired by MedImmune.
Competitors of AlphaCore Pharma
AlphaCore Pharma has 3 listed competitors in our database, 3 of them funded. They include Portola Pharma, MyoKardia and Cellino.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| portola.com | 2003 | San Francisco, United States | $296.09M | 369 | Therapeutics for cardiovascular and autoimmune diseases are developed. | |
| myokardia.com | 2012 | San Francisco, United States | $98M | 224 | Specialized drugs are developed for genetic heart diseases. | |
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies |
Detailed competitors of AlphaCore Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AlphaCore Pharma
The website of AlphaCore Pharma (alphacorepharma.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with AlphaCore Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for AlphaCore Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
3 companies that operate in the same segment as AlphaCore Pharma (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AlphaCore Pharma
AlphaCore Pharma was founded in 2007.
AlphaCore Pharma is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
AlphaCore Pharma, based in Ann Arbor, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and protein treatments. Develops protein therapeutics for treating cardiovascular diseases like atherosclerosis. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
AlphaCore Pharma's top competitors include Cellino, MyoKardia and Portola Pharma.
AlphaCore Pharma has 1 investor. Key investors include MedImmune.
Yes. AlphaCore Pharma was acquired by MedImmune in April 2013.
The website of AlphaCore Pharma receives about 681 thousand visits a month.